Detalhe da pesquisa
1.
Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes.
Muscle Nerve
; 69(6): 719-729, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593477
2.
Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis.
Mult Scler
; 29(1): 92-106, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36113170
3.
A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis.
Muscle Nerve
; 65(3): 291-302, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890069
4.
Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells.
J Autoimmun
; 67: 57-64, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26489998
5.
Experimental Autoimmune Myasthenia Gravis (EAMG): from immunochemical characterization to therapeutic approaches.
J Autoimmun
; 54: 51-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24970384
6.
Serum CCL24 as a Biomarker of Fibrotic and Vascular Disease Severity in Systemic Sclerosis.
Arthritis Care Res (Hoboken)
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589291
7.
The Role of CCL24 in Primary Sclerosing Cholangitis: Bridging Patient Serum Proteomics to Preclinical Data.
Cells
; 13(3)2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38334601
8.
CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis.
JCI Insight
; 8(12)2023 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345655
9.
Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.
J Autoimmun
; 36(2): 135-41, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21193288
10.
The susceptibility of Aire(-/-) mice to experimental myasthenia gravis involves alterations in regulatory T cells.
J Autoimmun
; 36(1): 16-24, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21035305
11.
MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model.
Stem Cell Res Ther
; 12(1): 72, 2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33468250
12.
MuSK EAMG: Immunological Characterization and Suppression by Induction of Oral Tolerance.
Front Immunol
; 11: 403, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32256489
13.
NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results.
Neurology
; 93(24): e2294-e2305, 2019 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740545
14.
Suppression of experimental autoimmune myasthenia gravis by combination therapy: pentoxifylline as a steroid-sparing agent.
J Neuroimmunol
; 201-202: 128-35, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18632163
15.
Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson's disease models.
FASEB J
; 21(8): 1870-83, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17314138
16.
Overexpression of phosphodiesterases in experimental autoimmune myasthenia gravis: suppression of disease by a phosphodiesterase inhibitor.
FASEB J
; 20(2): 374-6, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16365386
17.
DNA microarray in search of new drug targets for myasthenia gravis.
Ann N Y Acad Sci
; 1107: 111-7, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17804538
18.
miRNA profiling of NurOwn®: mesenchymal stem cells secreting neurotrophic factors.
Stem Cell Res Ther
; 8(1): 249, 2017 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29116031
19.
Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis.
Oncotarget
; 7(7): 7550-62, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26771137
20.
Effects of MSC-NTF cells on T and B regulatory cell function in ALS.
Amyotroph Lateral Scler Frontotemporal Degener
; 21(7-8): 638-639, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32808546